A Study of Volociximab in Metastatic Melanoma

Clinical trial NCT00369395 · TERMINATED

Trial details

NCT number: NCT00369395
Sponsor: Abbott
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IV Melanoma

Start date: 2006-12-01
Primary completion: 2008-03-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.